Basaglar Gets FDA Green Light
The U.S. Food and Drug Administration today approved Basaglar (insulin glargine injection), a long-acting human insulin analog to improve glycemic control in adult and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.
Common Rx Combo Tied to Serious Health Risk
The popular blood thinner warfarin is known for its potentially serious interactions with many drugs. And here may be another.
Type 2 Diabetes Rx May Pose Serious Health Risks
An FDA safety review has resulted in adding warnings to the labels of a specific class of type 2 diabetes medicines called sodium-glucose cotransporter-2 (SGLT2) inhibitors about the risks of too much acid in the blood and of serious urinary tract infections.
Insulin Management System May Malfunction
On November 2, 2015, Insulet Corporation (Insulet or the Company) initiated a lot-specific voluntary Field Safety Notification (Notification) for 15 lots of the OmniPod (Pod) which were distributed in the U.S. and three lots which were distributed internationally.
Got Type 1? Type 2 Rx May Not Help
For overweight teens with type 1 diabetes, good blood sugar control can be hard to come by.
A Breastfeeding Benefit — for Mom
Breastfeeding is known to provide a wide range of potential health benefits for babies. But what about for moms?
Diabetes Rx Kept Fatty Liver at Bay
A medication used in the treatment of type 2 diabetes may have the power to combat another common condition.
How Viagra Could Help Prevent Type 2 Diabetes
The little blue pill might have found another use outside the bedroom.
Diabetic Eye Disease Rx Delivers Results
A drug approved to treat a severe diabetic eye disease may soon be able to help with another.
The Benefits of Insulin Pumps
Parents of kids with type 1 diabetes may now have an easier time with the debate surrounding the insulin pump.